Komori
M

MANAC Chemical Partners Co.,Ltd

4360Materials and ChemicalsMicro cap
987JPY-1.1%
★ Watch (sign-up required)
Price history
¥987Latest+70.2%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview

The Group operates chemical-related businesses centered on マナック・ケミカル・パートナーズ. Its three core businesses are fine chemicals, flame retardants and health support, with management guidance provided primarily to マナック株式会社, 錦海化学株式会社 and マナック（上海）貿易有限公司. Following organizational restructuring, including the closure of the Shonan Innovation Research Institute, the Group is pursuing the creation of high-value-added products, the development of new technologies and expansion into new fields. External customer sales were ¥10,993 million in the fine chemicals business, ¥4,545 million in the flame retardants business and ¥1,415 million in the health support business, for a total of ¥10,993 million in the fiscal year ending March 2026, with the overall total also stated as the same amount. Sales by region were ¥9,886 million in Japan, ¥862 million in Asia and ¥243 million in Europe, for a total of ¥10,993 million. The Group disclosed its total investments, management policy and medium-term plan, including research and development expenses of ¥342 million.

Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
Loading
Documents
See all timely disclosuresSee all statutory filings
News
See all news
Key numbersShowing 8 of 20
PER
29.67How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.
PBR
0.73How many times the company's net assets? Around 1x is generally considered a benchmark.
ROE
2.5%Earning power. A figure above 10% is generally considered good.
Dividend yield
0.0%The annual dividend as a percentage of the share price.
Market capitalization
¥8.6bnShare price × number of shares. The value of the entire company.
Equity ratio
73.0%The proportion of assets funded by money that does not have to be repaid.
Operating margin
11.8%The percentage of revenue remaining from the company’s core business.
Revenue growth (3 years)
6.5%The average annual growth in sales over the past three years.
What to watch next
The point at which progress in ramping up large pharmaceutical projects in fine chemicals is reflected continuously in sales and profit
Second half of 2026 to 2027Impact HighLikelihood Medium
Completion of the fine chemicals capacity expansion at the Fukuyama Plant (¥150 million investment, work beginning in December 2026 and completion scheduled for March 2027), followed by stable operations and contributions from increased production
From March 2027 onwardImpact MediumLikelihood Medium
Ramp-up of operations at facilities related to metal-management technology (¥100 million investment, work beginning in April 2026 and completion scheduled for May 2026), together with stabilization of quality
April 2026 through the second half of 2026Impact MediumLikelihood Medium
The strengthening of facilities and technological capabilities related to bromine compounds after 錦海化学 becomes a consolidated subsidiary begins to flow through to earnings
Second half of 2026 to 2027Impact MediumLikelihood Low
Continued revisions to selling prices in the flame-retardants business and absorption of the impact of declining demand, through both volumes and prices
Second half of 2026 to 2027Impact HighLikelihood Medium
What to watch next
Loading
Who owns itTop holders total 55.6%
Listed holders 55.6%Everyone else 44.4%
TOSOH CORPORATION19.67%
Matsunaga Foundation16.40%
Suginohara Shoji (杉之原 祥二)5.69%
The Hiroshima Bank, Ltd.3.95%
株式会社合同資源2.45%
マナック社員持株会1.86%
光和物産株式会社1.48%
SUGAI CHEMICAL INDUSTRY CO.,LTD.1.47%
2 other listed holders2.66%
Who owns it
HolderOwnership (%)
TOSOH CORPORATION19.67
Matsunaga Foundation16.40
Suginohara Shoji (杉之原 祥二)5.69
The Hiroshima Bank, Ltd.3.95
株式会社合同資源2.45
マナック社員持株会1.86
光和物産株式会社1.48
SUGAI CHEMICAL INDUSTRY CO.,LTD.1.47
2 other listed holders2.66
This company's documents
Filings
Timely disclosures